{"id":"https://genegraph.clinicalgenome.org/r/f1fc0c8a-90bc-4274-8187-ed756c2278a8v1.0","type":"EvidenceStrengthAssertion","dc:description":"There has been sufficient amount of evidence published associating the SMARCA4 gene with rhabdoid tumor predisposition syndrome 2 (RTPS) since the gene-disease relationship was first proposed by Schneppenheim et al. (2010). Plenty of case level studies have been performed with RTPS patients that have variants in the SMARCA4 gene. SMARCB1, another subunit of the SWI/SNF chromatin remodeling complexes, also cause RTPS. Tumor cells from patients lacked SMARCA4 immunoreactivity and depletion of SMARCA4 increase cell growth. Reintroduction of SMARCA4 in SMARCA4-null H1299 cells resulted in a dose-dependent suppression of cell growth. SMARCA4 heterozygote mice are predisposed to exencephaly and tumors. All of these evidences suggest a definitive relationship between the SMARCA4 gene and rhabdoid tumor predisposition syndrome 2 (RTPS).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/f1fc0c8a-90bc-4274-8187-ed756c2278a8","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e5edb191-f515-47a3-b1d8-cc723eaef665","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e5edb191-f515-47a3-b1d8-cc723eaef665_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2018-06-29T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/e5edb191-f515-47a3-b1d8-cc723eaef665_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-01T00:00:00Z","role":"Publisher"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5edb191-f515-47a3-b1d8-cc723eaef665_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5edb191-f515-47a3-b1d8-cc723eaef665_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c54aab9b-a300-4da5-926c-8602e2ac8c36","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0655538d-dc5d-43e1-97df-be0f041b2e9c","type":"Finding","dc:description":"Brg1 +/- mice were predisposed to exencephaly (5 of 36) and tumors (3 of 20 displayed large subcutaneous tumors localized to the neck or inguinal regions) (Figure 2).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11163203","rdfs:label":"Brg1 Heterozygous Phenotype","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/86799893-4f3d-4233-8083-09c27e2d0492","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a29fbf3c-7c39-45d9-a759-f6bec2263c65","type":"Finding","dc:description":"Re-expression of SMARCA4 resulted in a dose-dependent suppression of cell growth. More p21 was also expressed, consistent with previous reports of the effect of SMARCA4 on cell cycle arrest.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658004","rdfs:label":"Reintroduce SMARCA4 in SMARCA4-null H1299 cells","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/e5edb191-f515-47a3-b1d8-cc723eaef665_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94bc19ae-9a94-4b6d-b8ed-396417c9d0ef","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f15ac18c-c418-4a9e-8b2e-99fddec7690d","type":"Finding","dc:description":"SMARCA4, as well as some other SWI/SNF components, play important roles in stem cell pluripotency, differentiation and development, and it is therefore conceivable that, without the central catalytic subunit, proliferation would not be controlled and a tumour may result.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658004","rdfs:label":"Deplete SMARCA4 increase cell growth","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ff176311-eb4f-4d22-876e-b758f11d164b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/64622234-7638-4fe6-b15a-ef801a416976","type":"Finding","dc:description":"SMARCA4 and SMARCB1 are two subunits of the SWI/SNF chromatin remodeling complexes and they physically interact with each other (Figure 1-3 and Figure 6-7). SMARCB1 (MIM 601607) cause Rhabdoid tumor predisposition syndrome 1 (MIM: 609322).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23540691","rdfs:label":"SMARCA4 and SMARCB1 interaction","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e6ad6f1a-68ee-4143-94e3-ecb76a7f7cfb","type":"EvidenceLine","dc:description":"Since four assays were done to support nonsense-mediated decay (RT-PCR, immunohistochemistry, immunoblot and recombinant expression studies in two cell lines), consider increase points to 1.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b375af5b-24da-4bd2-80fb-2036e7117b65","type":"Finding","dc:description":"RT-PCR on the patient’s lymphoblastoid cells (Figure 2A) and expression studies (Figures 2C-2G) indicated nonsense-mediated decay as the molecular mechanism for the lack of SMARCA4 expression in the tumors.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20137775","rdfs:label":"Tumor cells from both cases lacked SMARCA4 immunoreactivity","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5},{"id":"https://genegraph.clinicalgenome.org/r/e5edb191-f515-47a3-b1d8-cc723eaef665_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5edb191-f515-47a3-b1d8-cc723eaef665_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1eac6673-e31a-4427-be80-d07ef52bfcd0_proband_score_evidence_line","type":"EvidenceLine","dc:description":"De novo and Nonsense-mediated decay","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ae754154-d260-4355-8139-05e781fc7048","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23775540","rdfs:label":"Mother","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"detectionMethod":"Whole-exome sequencing and confirmed by Sanger sequencing.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"ORPHA:99966,  Atypical teratoid rhabdoid tumor","previousTesting":true,"previousTestingDescription":"The patients were originally reported by Poremba et al. (1993) as having immature teratomas. PMID: 8269278","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1eac6673-e31a-4427-be80-d07ef52bfcd0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23775540","allele":{"id":"https://genegraph.clinicalgenome.org/r/9238f4f4-204b-4ca6-84ac-52310ab9b79c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003072.3(SMARCA4):c.3533G>A (p.Trp1178Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/139439"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes"}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e5edb191-f515-47a3-b1d8-cc723eaef665_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2591ab83-a78e-4d05-9153-260994141bf5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Nonsense-mediated decay","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6025c0f3-5139-4fa8-b9ae-58b8f810c169","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","rdfs:label":"family 2","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Whole-exome sequencing and confirmed by Sanger sequencing.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"ORPHA:370396, Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2591ab83-a78e-4d05-9153-260994141bf5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","allele":{"id":"https://genegraph.clinicalgenome.org/r/4d1205ad-d177-401b-9735-8d4fe8181b69","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128849.1(SMARCA4):c.643C>T (p.Gln215Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/139441"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e6496b60-b2fd-439e-a623-bc805f4f5400_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Nonsense mutation","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f8fe4ad-fcf0-4d67-89c7-87c0785fb908","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658004","rdfs:label":"Case 111","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sequencing of all protein-coding exons in 279 cancer-related genes.","firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:370396, Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/e6496b60-b2fd-439e-a623-bc805f4f5400_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658004","allele":{"id":"https://genegraph.clinicalgenome.org/r/0987b012-4986-45b4-b419-cf72dfda35f2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000019.10:g.11024370C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404058925"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/5d99690e-4af2-4abf-a0e7-6ce3635e5baa_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Splice site mutation","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/31baf953-221e-4723-b9bb-d6610eb88e2b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","rdfs:label":"family 1","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Whole-exome sequencing and confirmed by Sanger sequencing.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"ORPHA:370396, Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","previousTesting":true,"previousTestingDescription":"PMID: 22424359","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/5d99690e-4af2-4abf-a0e7-6ce3635e5baa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","allele":{"id":"https://genegraph.clinicalgenome.org/r/fc8409c8-1712-4c63-be38-309e6cd0fa48","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128845.1(SMARCA4):c.4071+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/139440"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bde6ce9b-2ed4-41c0-b2fb-270b39cb3035_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Nonsense mutation","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ca80f8a3-7968-4924-812d-04c564e304ca","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658001","rdfs:label":"SCCO-008","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":9,"detectionMethod":"Next generation sequencing on a series of tumors and germline samples from 12 SCCOHT cases (9 tumors with 4 matched germline samples and 3 additional germline samples).","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"ORPHA:370396, Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/bde6ce9b-2ed4-41c0-b2fb-270b39cb3035_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658001","allele":{"id":"https://genegraph.clinicalgenome.org/r/50da4ad3-9629-4cd2-8ec0-f5ca5deb602e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000019.10:g.11023593C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA404057622"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ed6d33de-990a-43da-9c3d-de6ef908c5b9_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Nonsense-mediated decay","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b64cde68-6136-4067-80e8-e88ed35ef813","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20137775","rdfs:label":"Patient III-2","ageType":"AgeAtDiagnosis","ageUnit":"Months","ageValue":8,"detectionMethod":"Sequence the exons and intron-exon borders of four candidate genes from the core unit of the SWI/SNF complex—SMARCA4 (MIM *603254), SMARCA2 or BRM (MIM *600014), SMARCC1 or BAF155 (MIM *601732), and SMARCC2 or BAF170 (MIM *601734)—in germline DNA derived from one of the affected siblings (III-3).","ethnicity":{"id":"cg:NotHispanicOrLatino"},"firstTestingMethod":"PCR","phenotypeFreeText":"ORPHA:99966  Atypical teratoid rhabdoid tumor","previousTesting":true,"previousTestingDescription":"SMARCB1 mutations were not detected in tumor cells or leukocytes. PMID: 16206192","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/ed6d33de-990a-43da-9c3d-de6ef908c5b9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20137775","allele":{"id":"https://genegraph.clinicalgenome.org/r/1a619107-b6f6-4d43-babb-6d3643bc30d5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128844.1(SMARCA4):c.3565C>T (p.Arg1189Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/6554"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/56761c56-455e-4fc5-987f-ee4c61423f71_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Frameshift mutation in exon 4","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f7ba0da6-0a64-4aa8-82ca-683cfff131bc","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658001","rdfs:label":"SCCO-017","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":10,"detectionMethod":"Next generation sequencing on a series of tumors and germline samples from 12 SCCOHT cases (9 tumors with 4 matched germline samples and 3 additional germline samples).","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"ORPHA:370396, Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/56761c56-455e-4fc5-987f-ee4c61423f71_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658001","allele":{"id":"https://genegraph.clinicalgenome.org/r/8e6ea35e-c8c1-4795-af9e-304e4e3bf42c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000019.10:g.10986555_10986568del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA658683094"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/7c8fa5eb-241a-4e4d-8dc6-c55d74c0514c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Nonsense-mediated decay owing to disruption of the splice site. This mutation caused the cDNA to retain part of intron 18, leading to the introduction of a premature stop codon (Supplementary Fig. 4).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ef68c5c9-ea9f-4b13-b2e4-3ce13d681c76","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","rdfs:label":"family 3","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Whole-exome sequencing and confirmed by Sanger sequencing.","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"ORPHA:370396, Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","previousTesting":true,"previousTestingDescription":"PMID: 19621450","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/7c8fa5eb-241a-4e4d-8dc6-c55d74c0514c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","allele":{"id":"https://genegraph.clinicalgenome.org/r/5440f0ac-08ad-4ea8-aabf-a485fda5e35f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128845.1(SMARCA4):c.2617-3C>G","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/139442"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":10},{"id":"https://genegraph.clinicalgenome.org/r/e5edb191-f515-47a3-b1d8-cc723eaef665_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67948b12-6a08-47a6-bea3-f9f6439a75a3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The mother’s tumor showed LOH and retained SMARCA4 staining, whereas the daughter’s tumor had a c.1326delC mutation (encoding p.Ser442Argfs*59) and showed loss of SMARCA4 staining (Supplementary Fig. 3). Reduce point because the SMARCA4 staining in mother is normal.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6ceaf1f-8038-486a-b8a5-1964ad9daf24","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","rdfs:label":"fourth family","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Sanger sequencing","firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"ORPHA:370396, Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/67948b12-6a08-47a6-bea3-f9f6439a75a3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","allele":{"id":"https://genegraph.clinicalgenome.org/r/cabe6587-e76b-48b0-9cb5-0598a654a778","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001128849.1(SMARCA4):c.3239G>A (p.Gly1080Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/139443"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.25}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/e5edb191-f515-47a3-b1d8-cc723eaef665_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/48c354e7-1b2a-461c-93f5-2d7b9a474ca7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","rdfs:label":"family 1","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/48c354e7-1b2a-461c-93f5-2d7b9a474ca7","type":"Family","rdfs:label":"family 1","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/31baf953-221e-4723-b9bb-d6610eb88e2b"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"ORPHA:370396, Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/31baf953-221e-4723-b9bb-d6610eb88e2b"}},{"id":"https://genegraph.clinicalgenome.org/r/2fd58672-8dda-4a3d-a2fb-ca60517169b7_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","rdfs:label":"family 3","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/2fd58672-8dda-4a3d-a2fb-ca60517169b7","type":"Family","rdfs:label":"family 3","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ef68c5c9-ea9f-4b13-b2e4-3ce13d681c76"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"ORPHA:370396, Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ef68c5c9-ea9f-4b13-b2e4-3ce13d681c76"}},{"id":"https://genegraph.clinicalgenome.org/r/219cce2d-71e5-450a-9170-f9dbc9d5b684_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20137775","rdfs:label":"Two sisters","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/219cce2d-71e5-450a-9170-f9dbc9d5b684","type":"Family","rdfs:label":"Two sisters","ethnicity":{"id":"cg:NotHispanicOrLatino"},"member":{"id":"https://genegraph.clinicalgenome.org/r/b64cde68-6136-4067-80e8-e88ed35ef813"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"ORPHA:99966  Atypical teratoid rhabdoid tumor","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/b64cde68-6136-4067-80e8-e88ed35ef813"}},{"id":"https://genegraph.clinicalgenome.org/r/0326a0ef-a96f-44d3-a905-9bbc4f07ce36_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","rdfs:label":"fourth family","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/0326a0ef-a96f-44d3-a905-9bbc4f07ce36","type":"Family","rdfs:label":"fourth family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/d6ceaf1f-8038-486a-b8a5-1964ad9daf24"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"ORPHA:370396, Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/d6ceaf1f-8038-486a-b8a5-1964ad9daf24"}},{"id":"https://genegraph.clinicalgenome.org/r/ec76183a-be6d-40b0-8a9e-de416d71ff6e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24658002","rdfs:label":"family 2","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/ec76183a-be6d-40b0-8a9e-de416d71ff6e","type":"Family","rdfs:label":"family 2","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6025c0f3-5139-4fa8-b9ae-58b8f810c169"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"ORPHA:370396, Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT)","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/6025c0f3-5139-4fa8-b9ae-58b8f810c169"}},{"id":"https://genegraph.clinicalgenome.org/r/74c2c20a-122f-4da4-a8e3-a5e8f5c88ac4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23775540","rdfs:label":"de novo","estimatedLodScore":0.3,"family":{"id":"https://genegraph.clinicalgenome.org/r/74c2c20a-122f-4da4-a8e3-a5e8f5c88ac4","type":"Family","rdfs:label":"de novo","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/ae754154-d260-4355-8139-05e781fc7048"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"ORPHA:99966,  Atypical teratoid rhabdoid tumor","phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/ae754154-d260-4355-8139-05e781fc7048"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":524,"specifiedBy":"GeneValidityCriteria5","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/kDXV_2V1NSA","type":"GeneValidityProposition","disease":"obo:MONDO_0013224","gene":"hgnc:11100","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e5edb191-f515-47a3-b1d8-cc723eaef665-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}